BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 17336101)

  • 1. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
    Matteucci E; Ridolfi E; Desiderio MA
    Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping transmembrane binding partners for E-cadherin ectodomains.
    Shafraz O; Xie B; Yamada S; Sivasankar S
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31157-31165. PubMed ID: 33229577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of miRNA and lncRNA in triple-negative breast cancer.
    Xu J; Wu KJ; Jia QJ; Ding XF
    J Zhejiang Univ Sci B; 2020 Sept.; 21(9):673-689. PubMed ID: 32893525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.
    Xie Z; Eagleson KL; Wu HH; Levitt P
    eNeuro; 2016; 3(4):. PubMed ID: 27595133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer.
    Sylvester PW
    Clin Transl Med; 2014 Dec; 3(1):30. PubMed ID: 26932375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells.
    Kim DC; Park KR; Jeong YJ; Yoon H; Ahn MJ; Rho GJ; Lee J; Gong YD; Han SY
    Oncol Lett; 2016 Feb; 11(2):991-997. PubMed ID: 26893681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.
    Rangasamy D; Lenka N; Ohms S; Dahlstrom JE; Blackburn AC; Board PG
    Curr Mol Med; 2015; 15(7):588-97. PubMed ID: 26321759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin.
    Wang LT; Liou JP; Li YH; Liu YM; Pan SL; Teng CM
    Oncotarget; 2014 Jul; 5(14):5651-62. PubMed ID: 25015091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.
    Akl MR; Ayoub NM; Mohyeldin MM; Busnena BA; Foudah AI; Liu YY; Sayed KA
    PLoS One; 2014; 9(5):e97622. PubMed ID: 24849787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.
    Ayoub NM; Akl MR; Sylvester PW
    Cell Prolif; 2013 Oct; 46(5):538-53. PubMed ID: 24033536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET: a critical player in tumorigenesis and therapeutic target.
    Graveel CR; Tolbert D; Vande Woude GF
    Cold Spring Harb Perspect Biol; 2013 Jul; 5(7):. PubMed ID: 23818496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.
    Stein GY; Yosef N; Reichman H; Horev J; Laser-Azogui A; Berens A; Resau J; Ruppin E; Sharan R; Tsarfaty I
    PLoS One; 2012; 7(9):e45969. PubMed ID: 23049908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1.
    Gross JC; Schreiner A; Engels K; Starzinski-Powitz A
    Mol Biol Cell; 2009 Aug; 20(15):3598-607. PubMed ID: 19515834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression.
    Götz R
    Cancer Cell Int; 2008 May; 8():7. PubMed ID: 18492263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of a direct extracellular interaction between Met and E-cadherin.
    Reshetnikova G; Troyanovsky S; Rimm DL
    Cell Biol Int; 2007 Apr; 31(4):366-73. PubMed ID: 17336101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells.
    Hiscox S; Jiang WG
    Biochem Biophys Res Commun; 1999 Aug; 261(2):406-11. PubMed ID: 10425198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells--regulation by Rho, Rac and Rab small G proteins.
    Kamei T; Matozaki T; Sakisaka T; Kodama A; Yokoyama S; Peng YF; Nakano K; Takaishi K; Takai Y
    Oncogene; 1999 Nov; 18(48):6776-84. PubMed ID: 10597286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.